Skip to content

Permira Nears Deal for U.K. Blood Plasma Lab BPL

  • Private equity firm could announce deal in coming weeks
  • Permira is also eyeing stake in Italian plasma group Kedrion
Updated on

Permira is nearing a deal to buy U.K.-based blood-plasma firm Bio Products Laboratory Ltd. from China’s Creat Group Corp., according to people familiar with the matter.

The British private equity firm could announce an acquisition in the coming weeks, the people said, asking not to be identified discussing confidential information. Separately, Permira is also considering investing in Italian plasma group Kedrion as part of its larger strategy for the sector, the people said.